Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00268489 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: pemetrexed disodium

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]